This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Oncology  • Skin Cancer  • Ophthalmology  • Ophthalmological Disorders  • Retinal/ Chorioretinal Disorders  • Dermatology  • Dermatologic Disorders  • Neoplasms  • Alert me on articles by topic  Social Bookmarking   What's this?

Effect on Visual Acuity and Electrophysiologic Findings

Caroline Jacobzone, MD; Catherine Cochard-Marianowski, MD; Ingrid Kupfer, MD; Samia Bettembourg, MD; Yves Dordain, MD; Laurent Misery, MD; Beatrice Cochener, MD; Bruno Sassolas, MD

Arch Dermatol. 2004;140:1258-1261.

Background  Visual disturbance in the course of melanoma is rare. Specific localized metastases and drug toxic effects are frequently the cause. Recognition of a retinopathy raises several questions when the diagnosis of melanoma-associated retinopathy (MAR) can be confirmed. Descriptions of such patients in dermatologic literature are rare and deserve attention because therapeutic decisions are mandatory.

Observations  A 70-year-old woman had a first melanoma in 1985 and a second primary melanoma in 1994. Axillary lymph node involvement occurred in November 2000, leading to surgery and chemotherapy. In December 2001, she had sudden bilateral visual loss, with shimmering blobs of color and flickering photopsias. Computed tomography and cerebral magnetic resonance imaging ruled out localized tumor on the eyes or optic nerves or evolution of disease. Ophthalmologic examination revealed a bilateral posterior uveitis, with hyalitis and progressive destruction of retinal pigment. The electrophysiologic data confirmed the diagnosis of MAR. Symptoms improved after systemic corticosteroid therapy, with no relapse after tapering doses despite worsening of melanoma.

Conclusions  As a rare paraneoplastic visual syndrome possibly leading to blindness, MAR is characterized by bipolar cell involvement without photoreceptor cell impairment. Also, MAR is linked to the presence of autoantibodies directed against melanoma antigens that cross-react with the rod bipolar cells of the retina. Corticosteroid therapy is rarely beneficial. Our case of MAR is noteworthy because it involved a woman, was associated with an uveitis, and improved with corticosteroid therapy.

From the Departments of Dermatology (Drs Jacobzone, Kupfer, Misery, and Sassolas) and Ophthalmology (Drs Cochard-Marianowski, Bettembourg, and Cochener), University Hospital of Brest, and the Department of Ophthalmology, Military Hospital (Dr Dordain), Brest, France. The authors have no relevant financial interest in this article.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?